The prevalence of (MDRB) is increasing worldwide; therefore, this study aimed to identify the most common MDRB in clinical specimens and meet the urgent need to develop new antibacterial drugs to control their intractable infection. Additionally, due to the confrontation of the infection associated with bacterial biofilms, which are difficult to treat, and cause problems to public health, which require real solutions. Bee Venom produced by the glands of (Apis mellifera) is a complex mixture of active peptides, enzymes, and amines. So, it is considered a fertile environment for research to achieve the goal of this study. The results of the specimen's examination showed that, from a total of 500 clinical specimens, there are 224 specimens exhibited no growth, while 276 were positive. From 276 positive cultures, 317 isolates were obtained. Out of the 317 bacterial isolates, 169 (53.3%) were Gram-negative bacteria (GNB), and 148 (46.7%) were Grampositive (GP). It was of this number 124 (39.1%) were multidrug-resistant (MDR) isolates of which 89 (71.77%) were Gram-negative type, including Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa and 35 (28.23%) were Gram-positive including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Staphylococcus haemolyticus and Enterococcus faecalis. Antibacterial assays showed that Bee Venom possesses strong potential effect against MDR isolates including both GNB and GPB. with a wide range of MICs and MLCs concentration-spacing between 3.125 -50 μg/mL and 6.25 -100 μg/mL, respectively against all MDR-GNB and GPB. It was found that GPB was more sensitive at lower concentrations of Bee Venom than GNB. In addition, Bee Venom sub-MICs values against the most biofilm bacterial produces namely; E. faecalis, P. aeruginosa, S. aureus, VRSA, S. haemolyticus and E. faecalis exhibited sharp reduction in their biofilms ranged between (63.8-92%) especially at ½ MICs according to each bacterium, exclude E. faecalis biofilm was moderately affected (39%). While, at another tested sub-MICs showed moderate, weak, and no antibiofilm effects.
Introduction
Antibiotic resistance was considered an essential threat to human health worldwide in clinical practice (Blair et al., 2015) . Most bacteria that triggered severe diseases and were once effectively treated with several distinct antibiotic groups have now become resistant often to many antibiotics (CDC, 2013; Laxminarayan et al., 2013) . A limited pipeline of new antibiotics production has complicated the problem of antimicrobial resistance, resulting in higher morbidity and mortality rates and higher health care costs (Walker and Fowler, 2011) . For instance, 25,000 people in Europe each year dies as a result of MDRB bacterial infections that cost the economy of the European Union € 1.5 billion annually (Walker and Fowler, 2011) . Also, over two million people in the U.S. are infected annually with multi-drug resistance bacteria, resulting in 23,000 deaths directly (Hampton, 2013; WHO, 2014). The situation is much worse in developing countries, including Egypt, where no precise estimates are available as most developing countries face a critical shortage of disease detectives and the necessary infrastructure for Health Information System and Surveillance (WHO, 2014) . The most crucial virulence factor plays a considerable role in the antibiotic-resistance is the biofilm formation, that described as a sessile microbial community in which cells are connected and integrated into a protective, extracellular polymeric matrix with a surface or other cell (Archer et al., 2014; Kiedrowski and Horswill, 2011; Lister and Horswill, 2014) . This nature of multiplication has changed the physiology of gene expression and protein manufacturing (Archer et al., 2014; Kiedrowski and Horswill, 2011) . Biofilm growth represents an essential role throughout infection by offering a defense against multiple clearance mechanisms (Lister and Horswill, 2014) . The biofilm matrix can hinder certain immunological defenses, like macrophages that show unfinished entry into the biofilm matrix and "frustrated phagocytosis" (Scherr et al., 2014) . Also, biofilm cells demonstrate enhanced antibiotic tolerance (de la Fuente-Núñez et al., 2013). Also, biofilms perform a key position in chronic disease progression (Lister and Horswill, 2014) . After a biofilm has been established, separate cells can spread from the initial biofilm and either seed fresh sight of infection or arbitrate an acute infection like sepsis (Costerton et al., 1999) . MDRB have been put forward several approaches to solve, but the development of new natural antimicrobial agents is the most significant. Therefore, intensive research has focused on developing new approaches to prevent and treat MDR-infection (Blair et al., 2015) . Bee venom (apitoxin), is a colorless liquid secreted by the glands of bees (Hegazi et al., 2015) . The bee venom has a complicated combination of enzymes, active peptides, and amines (Hider, 1988) . Bee venom has, since ancient times been used in primitive therapy for healing diseases because of its biological activity (Son et al., 2007) . Therefore, the goal of the current research was to identify the most common MDR-isolates in some clinical specimens and evaluate the antibacterial and antibiofilm activity of Bee Venom from Apis mellifera' on isolated MDR-GNB and GPB.
Specimens and Methods

Venom collection
Bee venom collector device: Bee venom collecting electric shock device CJ 401 (Chung-Jin Biotech Ltd., Ansan, Korea) consists of digital control board, five bee venom collection frames, wire electrodes, and battery. Input / Output Voltage: 12 VDC Collector Frames: 46 cm x 28 cm. Honey bee was subjected to bee venom collecting electric shock device, at the Plant Protection, Department, Faculty, of Agriculture, Al-Azhar University. The device consists of a five bee venom collection frames with wire electrodes installed in parallel to each other. Each frame was placed on the top of the combs in every hive and then was connected to an electro-stimulator. Electrical impulses stimulate the bee workers to sting through latex sheet placed on a glass plate of the device frame. Bees that come into contact with the wires received a mild electrical shock and stung onto the glass sheet. The processing of dry bee venom scraping was implemented by sharp scraper under laboratory conditions, after that dry bee venom was weight, recorded and packed up in the dark glass jars and stored in a cool and dry place.
Specimens collection
In this study, starting from April 2017 to November 2017, a total of 500 clinical specimens were obtained. Specimens types were an abscess, pus, sputum, and urine, from medical analysis laboratories of; Desuoq general hospital Kafr Al sheikh governorate. The specimens were immediately transported in sterilized box, swabs, or tubes to the laboratory for bacteriological analysis (Miller, 2005) .
Bacterial isolation and maintenance media
Bacteria were isolated from clinical specimens by agar streaking method onto surface plates of nutrient agar and blood agar media, and then the Petri dishes were placed in the incubator for 24h, at 37 • C aerobically. After growth, bacterial colonies were subjected to purification processes and maintained on slants for identification and further use (Barrow and Feltham, 1993).
Antibiotic Susceptibility Testing and Isolates Identification:
The antibiotic susceptibility patterns of Ampicillin (10 mcg), Flucloxacillin (5 mcg), vancomycin (30 μg), (5 mcg), Clindamycin (2 mcg), Levofloxacin (5 mcg), Erythromycin (15 mcg), Kanamycin (30 mcg), Tobramycin (10 mcg), Ofloxacin (5 mcg), Rifamycin (30 mcg), Aztreonam (1 mcg), Gentamicin (10 mcg), Norfloxacin (10 mcg), Gatifloxacin (5 mcg), Cephradine (30 mcg), Tetracycline (30 mcg), Ciprofloxacin (5 mcg) and Oxacillin (1 mcg) were performed using the antibiotic disk diffusion method (CLSI, 2009 ). Incubation at 37 • C for 24 h. The zones of bacterial growth inhibition according to the antibiotic pattern were classified according to bacteria was sensitive, intermediately sensitive, or resistant per antibiotic. All MDR-clinical isolates were primary identified using Morphological characteristics of bacterial colonies according to Bergey's manual, 
Screening of antibacterial activity of Bee Venom
Bacterial isolates
The most encountered MDRB were, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa (GNB), Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Staphylococcus haemolyticus and Enterococcus faecalis (GPB).
Inoculum preparation
The bacterial isolates were cultured in Mueller-Hinton broth (MHB) media to a mid-logarithmic phase. The bacterial isolates were then suspended and adjusted by comparison against 0.5 Mc-Farland turbidity standard (1.5 × 10 8 cfu/ml) tubes. The resulting suspension was further diluted to a final of 5X10 6 cfu/ml (CLSI, 2009).
Disc diffusion method
This method has been done according to NARMS (2002); Surendra et al. (2011).
A sterile cotton swab was used for spreading diluted culture samples at a concentration (5X10 6 cfu/ml) on (MH) agar plates. The impregnated discs (7-mm) by Bee Venom at a concentration (200 μg/ml); were then placed on the MH agar's surface. The plates were investigated after the incubation period between 24 to 28hrs, at 37 • C and the inhibition zones were determined. The means ±SE of results each experiment was calculated using Microsoft Excel.
Broth microdilution method
Diluted culture inoculum at a concentration (5X10 6 cfu/ml) prepared from a fresh subculture of tested bacteria in Broth media. Bacterial suspension in MHB then loaded in the wells of polystyrene plate exclude three wells contains only MHB media as (background control). Bee Venom sample at a concentration (200 μg/ml) was used in each well except three wells containing bacterial suspension without Bee Venom as (Growth control). After an incubation period of 24h at 37 °C, the O.D.620nm was measured using absorbance microtiter plate reader at the Bot. and Micro., Dep., Fac., of sci., Al-Azhar University (Sunrise™-TECAN, Switzerland). The results were recorded as means ±SE of the triplicate experiment (NCCLS/CLSI, 2007) .
Minimum inhibitory concentrations (MICs) and minimal lethal concentration (MLCs)
The MIC was determined by the broth micro dilution method using 96-well microplates (Saini et al., 2005; NCCLS/CLSI, 2007) . The bacterial inoculum concentration of (5x10 6 CFU/ml) was obtained in each well. Bee Venom sample (1.0 mg) was dissolved in DMSO (1 mL) to obtain 1000 μg/mL stock solution to obtain ten dilutions, were 200, 100, 50, 25, 12.5, 6.25, 3.125, 1.562, 0.781 and 0.390 μg/mL and applied against the microscopic MDR-organisms in MHB media. Three wells containing bacterial suspension without Bee Venom used as (Growth control) and the (background control) are three wells containing media without bacterial inoculum. The O.D.620nm was measured using absorbance microtiter plate reader at the Bot. and Micro., Dep., Fac., of Sci., Al-Azhar University (Sunrise™-TECAN, Switzerland). The lowest concentration showing no growth was taken as the (MIC). After 24 h incubation, 0.1 ml from each well was sub-cultured in (MHA) plates and overnight incubated at 37 °C. The lowest concentration of VB, which gave a viable count of less than 0.1% of the original inoculums (5x10 6 CFU/ml) was assumed as the minimal lethal concentration (MLC).
Biofilm formation assay
All MDR-strains were tested to determine its ability to form the biofilm (quantitively) using tissue culture plate method (TCP) as described by Bekir et al. (2011). MDR-isolates were cultivated overnight in 96-well polystyrene tissue culture microtiter plates at 37 • C, with trypticase soy broth supplemented with 0.25% glucose as the growth medium. After incubation, the culture medium was removed and attached bacteria fixed by 95% ethanol, and stained with 1% crystal violet. Optical density (570 nm) was measured. Isolates exhibit O.D.570 nm > 0.1 considered as positive for biofilm production. Biofilm production was interpreted as strong, moderate, or low, according to StepanoviĆ et al. (2007) . The experiment was performed in triplicate.
Antibiofilm activity of Bee Venom
Antibiofilm activities of Bee Venom was determined at five concentrations sub-MICs against most biofilm producing strains were, P. aeruginosa (50 μg/mL), E. cloacae (25 μg/mL), S. aureus (6.25 μg/mL), Methicillin-resistant S. aureus (12.25 μg/mL), Vancomycin-resistant S. aureus (12.25 μg/mL), S. haemolyticus (6.25 μg/mL), and E. faecalis (3.125 μg/mL). Isolates were incubated with Bee Venom in microtiter plates, and the procedure was performed as previously described according to Bekir et al. (2011) . For each isolate, three replicates values were considered.
Results
Bacterial isolates and antibiotic resistance patterns
Results of examined all clinical specimens, showed that, there are 224 specimens exhibited no growth, while 276 were positive. A total of 317 isolates were obtained from 276 positive specimens. Two hundred and ninety-one of these isolates (91.8%) obtained from single infection specimens, while 26 bacterial isolates (8.2%) obtained from mixed infection specimens. Out of the 317 bacterial isolates, 169 (53.3%) were Gram-negative, and 148 (46.7%) were Gram-positive. It was found that, out of 317 bacterial isolates; 124 (39.1%) were MDR-isolates of which 89 ( 
Antibacterial activity of Bee Venom
The antibacterial activity of Bee Venom was evaluated by disk diffusion and broth microdilution methods in order to confirm the results obtained. It was found that the results of both methods show the antibacterial strength of bee venom at 200μg/mL. The results included in the table (1) and illustrated in figure (2) demonstrated 100% growth inhibition percentage against all tested MDR-isolates. In particularly, S. aureus (figure 3), E. faecalis and S. haemolyticus showed the highest inhibition zones diameter, were 37±0.75, 36.5±0.75 mm and 35±0.69 mm, respectively (table1& figure1). While, Methicillinresistant and vancomycin-resistant types of S. aureus exhibited the lowest diameter of inhibition zones than other (GNB) were 25.4±0.98 and 28±0.95 mm, respectively (table1& figure1). Bee Venom had a marked increased inhibition zones diameter against MDRisolates of E. coli and E. cloacae with 34±1.45 and 31±1.2 mm, respectively. While, P. aeruginosa and K. pneumoniae inhibition zones diameter were less in size than the previous two organisms with 21.6±0.75 and 25±0.85 mm, respectively (table1& figure 2). 
Minimum inhibitory concentrations (MICs) and minimal lethal concentration (MLCs)
From the obtained results, Bee Venom showed strong antibacterial activity with a wide range of MICs and MLCs concentration-spacing between 3.125 -50 μg/mL and 6.25 -100 μg/mL, respectively against all MDR-GNB and GPB one. It was found that GPB was more sensitive at lower concentrations of Bee Venom than GNB since E. faecalis was the highest sensitive organism with 3.125 μg/mL, and the MLC value was at 6.25 μg/mL. Moreover, then in the sensitivity comes both S. aureus and S. haemolyticus seemed to be the most sensitive after the previous bacterium 6.25 and 12.5 μg/mL for MICs and MLCs, respectively for both MDR-isolates. However, compared with the previous GPB MRSA and VRSA isolates needed higher concentrations of Bee Venom 12.5 μg/mL (MICs) and 50 μg/mL (MLCs) to inhibit their growth or even death altogether, table (1) and figure (4) . In contrast, GNB were less influential than the previous organisms except for E. coli a stronger effect had been reported, where it required less concentration (12.5 μg/mL) and was similar to prevent growth (MIC) as well as, murder (MLC) compared to other GNB. It was found that the highest MICs and MLCs values were against both P. aeruginosa and K. pneumoniae, where MICs were at 50 μg/mL and MLCs at 100 μg/mL for each bacterium. The MIC and MLC values for the last remaining MDR-isolate, namely, E. cloacae were recorded at 25 and 50 μg/mL, respectively table (1) and figure (4). 
Biofilm formation by MDR-bacterial isolates
Biofilm production of MDR strains makes the treatment using conventional antibiotics more difficult. The ability of tested MDR-GNB and GPB isolates in the current study was investigated by crystal violet staining of culture in 96 polystyrene well plates. Among the 9 tested isolates biofilm formation was strong in 6 (66.7%), namely; E. cloacae, P. aeruginosa, S. aureus, VRSA, S. haemolyticus and E. faecalis with optical densities (O.D.570nm) were, 1.3, 1.1, 1.43, 1.12, 1.34 and 1.5, respectively. Only, E. coli demonstrated weak biofilm pattern 0.211 O.D.570nm, while K. pneumonia, and MRSA showed a moderate biofilm production were 0.41 and 0.64 (O.D.570nm) respectively, figures (5&6). 
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Anti-biofilm formation effect of Bee Venom against MDR-GNB and GPB isolates
The anti-biofilm activity of VB sub-MICs was assessed against the most MDRbiofilm producers. From the obtained results (figure 7) it was found that planktonic growth of E. cloacae was not affected by sub-MIC concentrations of Bee Venom, while biofilm formation was strongly inhibited by 84%, 68% at ½ MIC and ¼ MIC respectively. Moderate attenuation 39% was showed at 1 / 8 MIC, figure (7). 
Figure 7. Effect of sub-MIC of Bee Venom on biofilm formation of MDR-E. cloacae
Biofilm formation of P. aeruginosa considered a key factor for organism survival and resistance. Bee Venom sub-MICs was nearly totally inhibited P. aeruginosa biofilm by 92% at ½ MIC. Other sub-MICs showed moderate to strong antibiofilm inhibition effect ranged between 28% to 77% with increasing sub-MIC concentration, figure (8).
Figure 8. Effect of sub-MIC of Bee Venom on biofilm formation of MDR-P. aeruginosa.
S. aureus considered as the gold standard Gram-positive biofilm producing bacteria, sub-MIC concentration Bee Venom had a potential relatively high effect of eradicating the biofilm by 63.8% at ½ MIC. While 37.8% and 18% biofilm eradication were achieved at ¼ and 1 / 8 of MIC. However, the S. aureus biofilm was not affected under low concentrations, figure (9). The biofilm producing MDR-VRSA isolate with different Bee Venom sub-MICs were screened for its ability to eradicate the formed biofilm to the wells of microtitration plate. Sub-inhibition doses of Bee Venom were relatively steep (78%) in biofilm depletion of this bacterium while the cell growth was not affected. Also, a 55% reduction in biofilm was obtained at ¼ of MIC, figure (10).
Figure 10. Effect of sub-MIC of Bee Venom on biofilm formation of MDR-VRSA.
As well as, the obtained results showed that, Bee Venom sub-inhibitory concentrations was able to decrease the biofilm production of S. haemolyticus by 68% and 35% at ½ and ¼ MICs respectively. While, low concentration showed low to no effect, figure (11). It was found that E. faecalis biofilm was less affected at ½ MIC only 39% reduction, compared to all MDR-GNB and GPB biofilms examined in this study at half sub-inhibitory concentration. As well as, at ¼ MIC showed low attenuation effect 19% while, other concentrations were completely ineffective, and this may be attributed to the low MIC value of this bacterium figure (12).
Figure 12. Effect of sub-MIC of Bee Venom on biofilm formation of MDR-E. faecalis.
Discussion
MDRB will continue to persist and spread around the world. They cause clinical failure in the treatment of infectious diseases by decreasing the efficacy of antibiotic therapy and tend to boost infection and government health problems ' seriousness, incidence and expenses (Alekshun and Levy, 2007; O'Neil, 2016) . Today the continuous implementation of new or enhanced antibiotics into clinical and agricultural environments has produced resistance to almost all recognized antibiotics (Barton, 2014; Clatworthy et  al., 2007) . It is, therefore, highly crucial for human health to proceed to produce new or improved antibiotics (Thomsen et al., 2016) . So, in this study, we aim to identify the MDRB in some clinical specimens against major antibiotics used in the treatment of bacterial infection. Moreover, then evaluation of the antibacterial activity of bee venom as a natural antimicrobial to control these MDRB, also to evaluate its ability to eliminate the MDR-bacterial biofilm, which is a key factor in drug-resistance.
In the current study, A total of 317 isolates were obtained from 276 positive clinical specimens. Out of the 317 bacterial isolates, 169 (53.3%) were GN, and 148 (46.7%) were Gram-positive. It was found that, out of 317 bacterial isolates; 124 (39.1%) were MDR isolates of which 89 (71.77%) were GP type, including E. coli, K. pneumoniae, E.cloacae, and P. aeruginosa and 35 (28.23%) were Gram-positive including S. aureus, Methicillinresistant S. aureus, Vancomycin-resistant S. aureus, S. haemolyticus and E. faecalis. In this study, 39.1% of isolates were resistant to antibiotics and therefore considered MDR isolates. This finding was in the same direction with the study conducted in Egypt by El- Mahallawy et al. (2015) , who reported that MDR was identified in 69% of bacteria isolated from positive blood cultures. Increased resistance in bacteria may be due to the uncontrolled use of antibiotics and their overuse lead to the rapid and extensive spread of antimicrobial resistance (Llor and Bjerrum, 2014) . Antimicrobial overuse is occurring in multiple sectors (human, animal, agriculture) (Aarestrup et al., 2008; O'Neil, 2016) . Microorganisms under the pressures of antimicrobial choice improve survival through acquisition and expression of resistance genes and then share them with other bacteria and processes such as gene overexpression and silencing, variety in the phase (Collignon et al.,  2018) . Some important resistance genes, such as beta-lactamases, are millions of years old (Gaze et al., 2013; Perry and Wright, 2014) . Soil and other environmental matrices are wealthy causes of very varied bacterial and genetic communities (Ruuskanen et al., 2016) . Thousands of tons of antimicrobials are manufactured every year and are brought into the environment (Singer et al., 2016; Van Boeckel et al., 2015) . Treatment plant and pharmaceutical waste, especially if not handled properly, can discharge elevated levels of antimicrobial substances into the surface water (Aubertheau et al., 2017; Singer et al.,  2016; So et al., 2015) . Antimicrobial residues are components of animal manure, human sewage, and aquaculture alongside fecal bacteria and resistance genes (Ruuskanen et al., 2016; Wang et al., 2018) . Waste treatment and manure composting decrease levels of certain but not all antimicrobials and microorganisms that are brought to the soil after land use of person and animal biosolids (Rahube et al., 2016) . Antibiotic residues can contribute to the development of antibiotic resistance in bacteria through selective pressure (Laxminarayan et al., 2013) . Specifically, maybe even the exposure of a bacterium to a single molecule of an antibiotic can favor natural selection for resistance, or a mutation developing resistance (Lundborg and Tamhankar, 2017) . Genes coding ESBLs are often plasmid-mediated and thus can be transferred between different bacterial strains within or between species (horizontal gene transfer), and this helps antibiotic resistance spread (Chandran et al., 2014) . Besides, ESBL-producing bacteria have shown co-resistance to quinolones, sulphonamides, and aminoglycosides (Maina et al., 2013) . In our study the most predominate bacterial isolates were GNB, in contrary, with our findings by Zahran et al. (2017) exhibited that, the predominant bacteria isolated from wound infection were GPB including S. aureus (27.4%), followed by coagulase-negative staphylococci (CoNS) (19.4%), Gram-negative K. pneumoniae (12.2%), E. coli and Enterobacter spp. (each 9.7%), P. mirabilis and P. aeruginosa (each 5.6%). Also, their study reported that S. aureus (27.4%) was the predominant organism, and 88.3% of S. aureus isolates were MRSA. As well as, another study was in harmony with our results in respect to the MDR-VRSA, their study found that a lot of S. aureus are resistant to several antimicrobial agents such as vancomycin which is regarded as the last staphylococci therapy choice (Jensen and Lyon, 2009) . Vancomycin resistance can be caused by the overproduction and retention of the cell wall content (including decreased autolytic exercise), by the activating cell wall structure that leads to cell wall thickening and reduced vancomycin access to its active site (Howden et al., 2010) . In consistence with our findings, S. haemolyticus was frequently isolated from human specimens and presented the highest level of antimicrobial resistance among the coagulase-negative staphylococci (CoNS), (Becker et al., 2014) . Also, our findings were in agreement with another study in Egypt by (Leandro et al., 2015) . Čujová et al. (2014) reported that honey Bee Venom contained melittin, which is more active against GPB than GNB.
As well as, it was found that, antimicrobial peptides (AMPs), which are typically less than 100 amino acids in length that exhibit antimicrobial activity can be obtained from the poisons of various animals, such as bees (Perumal Samy et al., 2017) . AMPs have a broad antimicrobial spectrum and are not affected by classical mechanisms of resistance to conventional antibiotics. AMPs interact primarily with the lipids of cytoplasmic membranes or cell walls, leading to membrane permeabilization, cell lysis, and death (Brogden, 2005) . AMP interaction with the lipid monolayer as described by Brogden (2005) can cause peptide aggregation forming pores, lipid and peptide combination forming a toroidal pore, or direct membrane disruption (O 'Brien-Simpson et al., 2018) .
Bacteria within biofilms are more resistant than those in the planktonic or sessile state. Studies have shown that biofilm cells can withstand up to 1000 times as many antibiotic concentrations as their planktonic peers, and are even prepared to endure in biocidal and UV-exposed settings (Otter et al., 2015) . This makes it very hard to eradicate them once they have reached their biofilm form (de la Fuente-Núñez et al., 2013) .
Our results demonstrated that among the tested isolates biofilm formation was strong in 66.7% of MDR-isolates, namely; E. cloacae, P. aeruginosa, S. aureus, VRSA, S. haemolyticus and E. faecalis. Bacteria generate biofilm because the virulence factor performs a major part in infection by protecting against many clearance mechanisms (Scherr et al., 2014) . The biofilm matrix can hinder certain immunological defenses, like macrophages that show unfinished entry into the biofilm matrix and "frustrated phagocytosis" (Scherr et al., 2014) .
From the obtained results, Bee Venom exhibited strong antibiofilm effect against tested MDR-GNB and GPB. As mentioned above, AMP in Bee Venom interact with the lipid as described by Brogden (2005) and therefore, cause peptide aggregation forming pores, lipid and peptide combination forming a toroidal pore, or direct membrane disruption (O'Brien-Simpson et al., 2018) . This distinctive intervention system enables AMPs to work on bacteria at various stages of biofilm, like structure, attachment, and dispersion (Batoni et al., 2016) . In a previous report, the AMP Macropin, from bee venom, was recognized and declared to be made of 13 amino acids thus, Macropin is less than Melittin, which makes it more economical to synthesize (Monincová et al., 2014) . Macropin had strong antibiofilm activity against MDRB including S. aureus and P. aeruginosa through a decrease in MBIC concentration of the peptide combined with antibiotics indicated that it could inhibit biofilm formation successfully (Dosler and Karaaslan, 2014) .
Conclusion
In the current study (39.1%) from bacterial isolates were MDR. Of which (71.77%) were Gram-negative type, including Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa and (28.23%) were Gram-positive including Staphylococcus aureus, MRSA, VRSA, Staphylococcus haemolyticus and Enterococcus faecalis. Also, this study revealed the potential effect of Bee Venom as antibacterial to control MDR-isolates as well as, its remarkable ability to eliminate biofilm, making bee venom a promising antibacterial that can be used in many different fields. Hider, R.C., 1988. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 12, 60-65.
